These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2552740)

  • 1. Prenatal Rh-immune prophylaxis with 300 micrograms immune globulin anti-D in the 28th week of pregnancy.
    Trolle B
    Acta Obstet Gynecol Scand; 1989; 68(1):45-7. PubMed ID: 2552740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal prophylaxis of Rh immunization with 250 micrograms anti-D immunoglobulin.
    Hermann M; Kjellman H; Ljunggren C
    Acta Obstet Gynecol Scand Suppl; 1984; 124():1-15. PubMed ID: 6095582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin.
    Thornton JG; Page C; Foote G; Arthur GR; Tovey LA; Scott JS
    BMJ; 1989 Jun; 298(6689):1671-3. PubMed ID: 2547468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region].
    Huchet J; Dallemagne S; Huchet C; Brossard Y; Larsen M; Parnet-Mathieu F
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):101-11. PubMed ID: 3035003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spontaneous antepartal RhD alloimmunization].
    Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
    Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rh immune globulin after genetic amniocentesis: impact on pregnancy outcome.
    Crane JP; Rohland B; Larson D
    Am J Med Genet; 1984 Dec; 19(4):763-8. PubMed ID: 6097129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures.
    Bowman JM; Pollock JM
    Transfus Med Rev; 1987 Aug; 1(2):101-12. PubMed ID: 2856541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation.
    Karanth L; Jaafar SH; Kanagasabai S; Nair NS; Barua A
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009617. PubMed ID: 23543581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-D administration in pregnancy for preventing rhesus alloimmunisation.
    Crowther CA; Keirse MJ
    Cochrane Database Syst Rev; 2000; (2):CD000020. PubMed ID: 10796088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adverse effects and patient information].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do Rh-negative women with first trimester spontaneous abortions need Rh immune globulin?
    Hannafin B; Lovecchio F; Blackburn P
    Am J Emerg Med; 2006 Jul; 24(4):487-9. PubMed ID: 16787810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of maternal RhD isoimmunization with anti-D gamma isoimmunization].
    Baptista-González HA; Rosenfeld-Mann F; Leiss-Márquez T
    Salud Publica Mex; 2001; 43(1):52-8. PubMed ID: 11270285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advantages of preventing Rh isoimmunization].
    Mikulandra F; Merlak I; Perisa M; Kapitanović Z; Barbetti V; Kimer M; Glavadanović N
    Jugosl Ginekol Perinatol; 1985; 25(1-2):29-34. PubMed ID: 3003466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antenatal anti-Rh(D) antigen prophylaxis of Rh/-/- pregnancy in women on first consultation at the St. Sofia Obstetrics-Gynecology Hospital -- Sofia].
    Katsulov A; Iankov M; Zlateva K; Blagova A; Gogova K; Savova S
    Akush Ginekol (Sofiia); 2001; 40 Suppl 5():7-8. PubMed ID: 11785356
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of the erythrocyte rosette test to screen for excessive fetomaternal hemorrhage in Rh-negative women.
    Stedman CM; Baudin JC; White CA; Cooper ES
    Am J Obstet Gynecol; 1986 Jun; 154(6):1363-9. PubMed ID: 3013010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated anti-D titer after the administration of Rh immune globulin. A case report.
    Andres RL; Branch DW; Scott JR
    J Reprod Med; 1989 Apr; 34(4):318-20. PubMed ID: 2497253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical high-risk designation does not predict excess fetal-maternal hemorrhage.
    Ness PM; Baldwin ML; Niebyl JR
    Am J Obstet Gynecol; 1987 Jan; 156(1):154-8. PubMed ID: 3026183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal anti-D prophylaxis during pregnancy does not cause neonatal haemolysis.
    Maayan-Metzger A; Schwartz T; Sulkes J; Merlob P
    Arch Dis Child Fetal Neonatal Ed; 2001 Jan; 84(1):F60-2. PubMed ID: 11124929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive feto-maternal haemorrhage: effect of passively administered anti-D in the prevention of Rh sensitization and haemolytic disease of the newborn.
    Mills L; Napier JA
    Br J Obstet Gynaecol; 1988 Oct; 95(10):1007-12. PubMed ID: 2847774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.